These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37806073)

  • 1. "It's a big added stress on top of being so ill": The challenges facing people prescribed cannabis in the UK.
    Beckett Wilson H; Metcalf McGrath L
    Int J Drug Policy; 2023 Dec; 122():104220. PubMed ID: 37806073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
    Sakal C; Lynskey M; Schlag AK; Nutt DJ
    Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.
    Fischer B; Daldegan-Bueno D; Boden JM
    Drug Alcohol Rev; 2020 Jul; 39(5):555-567. PubMed ID: 32436274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
    Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey.
    Assanangkornchai S; Thaikla K; Talek M; Saingam D
    PeerJ; 2022; 10():e12809. PubMed ID: 35047242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Something that actually works": Cannabis use among young people in the context of street entrenchment.
    Paul B; Thulien M; Knight R; Milloy MJ; Howard B; Nelson S; Fast D
    PLoS One; 2020; 15(7):e0236243. PubMed ID: 32722721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can drug policies modify cannabis use starting choice? Insights from criminalisation in Italy.
    Benedetti E; Lombardi G; Molinaro S
    Adv Life Course Res; 2023 Dec; 58():100566. PubMed ID: 38054868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement.
    Fehr F; Lo LA; Nelson C; Nanson K; Diehl L; Nielson K; Reddon H; Walsh Z
    Int J Ment Health Nurs; 2024 Feb; 33(1):195-201. PubMed ID: 37767954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing heterogeneity among people who use cannabis for medicinal reasons: A latent class analysis of a nationally representative Canadian sample.
    Coelho SG; Wardell JD
    Int J Drug Policy; 2023 Jul; 117():104076. PubMed ID: 37247474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician Attitudes, Training, and Beliefs About Cannabis: An Interprofessional Assessment.
    Worster B; Ashare RL; Hajjar E; Garber G; Smith K; Kelly EL
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):547-556. PubMed ID: 34978882
    [No Abstract]   [Full Text] [Related]  

  • 15. Recreational Cannabis Use: Regulatory Aspects, Public Opinion and Concerns for Public Health.
    Scopetti M; Padovano M; Peruch M; Concato M; Livieri T; Radaelli D; D'Errico S
    Curr Pharm Biotechnol; 2023; 24(6):728-740. PubMed ID: 35996264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building smart cannabis policy from the science up.
    Weiss SRB; Howlett KD; Baler RD
    Int J Drug Policy; 2017 Apr; 42():39-49. PubMed ID: 28189459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scandalous decisions: explaining shifts in UK medicinal cannabis policy.
    Monaghan M; Wincup E; Hamilton I
    Addiction; 2021 Jul; 116(7):1925-1933. PubMed ID: 33404120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 19. So near yet so far: why won't the UK prescribe medical cannabis?
    Nutt D; Bazire S; Phillips LD; Schlag AK
    BMJ Open; 2020 Sep; 10(9):e038687. PubMed ID: 32958492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
    Isaac S; Saini B; Chaar BB
    PLoS One; 2016; 11(5):e0155113. PubMed ID: 27171490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.